Deep brain stimulation for psychiatric disorders: where we are now

Abstract

<jats:p>Fossil records showing trephination in the Stone Age provide evidence that humans have sought to influence the mind through physical means since before the historical record. Attempts to treat psychiatric disease via neurosurgical means in the 20th century provided some intriguing initial results. However, the indiscriminate application of these treatments, lack of rigorous evaluation of the results, and the side effects of ablative, irreversible procedures resulted in a backlash against brain surgery for psychiatric disorders that continues to this day. With the advent of psychotropic medications, interest in invasive procedures for organic brain disease waned.</jats:p> <jats:p>Diagnosis and classification of psychiatric diseases has improved, due to a better understanding of psychiatric patho-physiology and the development of disease and treatment biomarkers. Meanwhile, a significant percentage of patients remain refractory to multiple modes of treatment, and psychiatric disease remains the number one cause of disability in the world. These data, along with the safe and efficacious application of deep brain stimulation (DBS) for movement disorders, in principle a reversible process, is rekindling interest in the surgical treatment of psychiatric disorders with stimulation of deep brain sites involved in emotional and behavioral circuitry.</jats:p> <jats:p>This review presents a brief history of psychosurgery and summarizes the development of DBS for psychiatric disease, reviewing the available evidence for the current application of DBS for disorders of the mind.</jats:p>

Persistent Microstructural Deficits of Internal Capsule in One-Year Abstinent Male Methamphetamine Users: a Longitudinal Diffusion Tensor Imaging Study

“…Our results could be helpful for choosing the target areas of deep brain stimulation (DBS) (Kravitz et al 2015). Internal capsule could be a potential target structure that has been used in the treatment of obsessive-compulsive disorders (OCD) (Cleary et al 2015), which share common psychopathology in compulsivity with substance use disorders (Voon et al 2015). Further studies with larger sample size will be needed to verify the present findings, which will give the potential implications for the treatment of MA abuse.…”

Functional Circuitry Effect of Ventral Tegmental Area Deep Brain Stimulation: Imaging and Neurochemical Evidence of Mesocortical and Mesolimbic Pathway Modulation

“…There seems to be a ceiling effect to the therapeutic benefits of DBS, where beyond a certain point, the detrimental side effects appear (Gibson et al, 2016a). Adverse effects observed in clinical trials, including hypomania, mania, and disinhibition (Malone et al, 2009; Bewernick et al, 2010; Dougherty et al, 2015) are comparable to the effects elicited by drugs of abuse in VTA-DBS animal studies (Cleary et al, 2015). …”

Interacting Neural Processes of Feeding, Hyperactivity, Stress, Reward, and the Utility of the Activity-Based Anorexia Model of Anorexia Nervosa

“…Since no technology is yet available for this type of study in humans, the ABA rodent could provide a vast amount of information—with potential application to neuromodulatory treatments, which are currently being investigated for use in AN. 354 …”